[Centre Activity] HKU Phase 1 Clinical Trials Centre Opens Door for Newly Admitted MBBS Students
02/09/2019
[Centre Activity] HKU Phase 1 Clinical Trials Centre Opens Door for Newly Admitted MBBS Students
02/09/2019
When most people think of medical careers, the life of a practicing doctor immediately come to mind. However, there is also a very different option in the medical field which involves an alternative pathway: be a medical researcher.
30 students who are newly admitted to the HKU Bachelor of Medicine and Bachelor of Surgery Programme (MBBS) this year visited HKU Phase 1 Clinical Trials Centre on July 8, 2019. An information session introducing the concepts of clinical research was delivered by Dr. Creany Wong, Associate Director of HKU-CTC, followed by a tour around the Centre.
The students reflected that it was an eye-opening experience as they had never thought of the possibility of entering the research field after the completion of a medical degree. Some considered that it could also be another way to contribute to the society and to the betterment of mankind.
[Study Completion] Successful Completion of Phase 1 Trial of New Asthma Drug!
01/09/2019
The investigational drug, Benralizumab, is a novel drug for treating asthma. It was approved in USA, European Union, Japan and Canada. HKU Clinical Trials Centre conducted the phase 1 clinical research of the drug to evaluate the metabolism and safety of the drug using different doses in Chinese population.
Recruitment started in March 2019 and 36 healthy volunteers were selected to join the study. The whole study took 17 weeks and it included screening, 3-day-2-night confinement and follow-up visits. Volunteers were divided into 2 groups to receive injection. The research was completed in August 2019.
Potential New Treatment for Advanced HCC Went Through Successful Phase 1 and Phase 2 Studies
31/07/2019
Potential New Treatment for Advanced HCC Went Through Successful Phase 1 and Phase 2 Studies
31/07/2019
Successful Study on New Drug for Chronic Lymphocytic Leukemia (CLL) Paves Way for Phase 2 Study on Efficacy and Safety of the Selected Dosage
24/07/2019
Successful Study on New Drug for Chronic Lymphocytic Leukemia (CLL) Paves Way for Phase 2 Study on Efficacy and Safety of the Selected Dosage
24/07/2019
Study Shows New Drugs for Hepatitis C Well-Tolerated in Chinese Participants
24/07/2019
Phase 1 Study Shows Effective Antiviral Response of Novel Drug for Hepatitis B Virus (HBV)
24/07/2019
Phase 1 Study Shows Effective Antiviral Response of Novel Drug for Hepatitis B Virus (HBV)
24/07/2019
Potential New Treatment for Advanced HCC Went Through Successful Phase 1 and Phase 2 Studies
24/07/2019
Potential New Treatment for Advanced HCC Went Through Successful Phase 1 and Phase 2 Studies
24/07/2019
Immunotherapy Drug Proven More Effective Than Traditional Sorafenib Treatment for HCC Patients
24/07/2019
Immunotherapy Drug Proven More Effective Than Traditional Sorafenib Treatment for HCC Patients
24/07/2019
